Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy

This study has been completed.
Information provided by:
NeurogesX Identifier:
First received: July 10, 2003
Last updated: March 4, 2008
Last verified: March 2008